BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38923759)

  • 1. HOXC6-mediated transcriptional activation of ENO2 promotes oral squamous cell carcinoma progression through the Warburg effect.
    Feng J; Fang J
    J Biochem Mol Toxicol; 2024 Jul; 38(7):e23752. PubMed ID: 38923759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-495 confers inhibitory effects on cancer stem cells in oral squamous cell carcinoma through the HOXC6-mediated TGF-β signaling pathway.
    You X; Zhou Z; Chen W; Wei X; Zhou H; Luo W
    Stem Cell Res Ther; 2020 Mar; 11(1):117. PubMed ID: 32171324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circ_0005320 promotes oral squamous cell carcinoma tumorigenesis by sponging microRNA-486-3p and microRNA-637.
    Zheng X; Du F; Gong X; Xu P
    Bioengineered; 2022 Jan; 13(1):440-454. PubMed ID: 34967281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIB3 promotes the growth of oral squamous cell carcinoma by regulating JNK/JUN-mediated aerobic glycolysis.
    Meng Z; Wang Y; Wang X; Han X
    Arch Oral Biol; 2024 Aug; 164():105977. PubMed ID: 38696945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NEDD4L inhibits glycolysis and proliferation of cancer cells in oral squamous cell carcinoma by inducing ENO1 ubiquitination and degradation.
    Zhang G; Zhao X; Liu W
    Cancer Biol Ther; 2022 Dec; 23(1):243-253. PubMed ID: 35316145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of PGK1 under hypoxic conditions promotes glycolysis and increases stem cell‑like properties and the epithelial‑mesenchymal transition in oral squamous cell carcinoma cells via the AKT signalling pathway.
    Zhang Y; Cai H; Liao Y; Zhu Y; Wang F; Hou J
    Int J Oncol; 2020 Sep; 57(3):743-755. PubMed ID: 32705252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect.
    Xu Q; Zhang Q; Ishida Y; Hajjar S; Tang X; Shi H; Dang CV; Le AD
    Oncotarget; 2017 Feb; 8(6):9557-9571. PubMed ID: 27926487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185-5p/PLOD1/Akt/mTOR pathway.
    Liu J; Zhang Y; Wu J; Liu X; Li L; Zhang J
    Cancer Genet; 2024 Jun; 284-285():48-57. PubMed ID: 38729078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HOXA1 silencing inhibits cisplatin resistance of oral squamous cell carcinoma cells via IκB/NF-κB signaling pathway.
    Zhu R; Mao Y; Xu X; Li Y; Zheng J
    Anticancer Drugs; 2024 Jul; 35(6):492-500. PubMed ID: 38477942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
    Han L; Cheng J; Li A
    Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
    [No Abstract]   [Full Text] [Related]  

  • 11. Long non‑coding RNA AFAP1‑AS1 facilitates the growth and invasiveness of oral squamous cell carcinoma by regulating the miR‑145/HOXA1 axis.
    Li M; Yu D; Li Z; Zhao C; Su C; Ning J
    Oncol Rep; 2021 Mar; 45(3):1094-1104. PubMed ID: 33650645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal miR-146b-5p derived from cancer-associated fibroblasts promotes progression of oral squamous cell carcinoma by downregulating HIPK3.
    He L; Guo J; Fan Z; Yang S; Zhang C; Cheng B; Xia J
    Cell Signal; 2023 Jun; 106():110635. PubMed ID: 36813147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HNRNPA2B1 promotes oral squamous cell carcinogenesis via m
    Wang X; Zhi M; Zhao W; Deng J
    IUBMB Life; 2024 Jul; 76(7):437-450. PubMed ID: 38265150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importin 7 enhances protective autophagy induced by nuclear translocation of homeobox A10 in oral squamous cell carcinoma.
    Chen S; Pan J
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):241-247. PubMed ID: 38650127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOXC13-AS accelerates cell proliferation and migration in oral squamous cell carcinoma via miR-378g/HOXC13 axis.
    Li W; Zhu Q; Zhang S; Liu L; Zhang H; Zhu D
    Oral Oncol; 2020 Dec; 111():104946. PubMed ID: 32763778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2).
    Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
    Curr Cancer Drug Targets; 2022; 22(9):771-783. PubMed ID: 35388759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression.
    Niu X; Yang B; Liu F; Fang Q
    Biomed Pharmacother; 2020 Jan; 121():109623. PubMed ID: 31731187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma.
    Zhu X; Du J; Gu Z
    Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Zhang J; Wu J; Chen Y; Zhang W
    Biochem Cell Biol; 2021 Aug; 99(4):424-434. PubMed ID: 34283652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.